PharmaJet Announces Implementation Study Results: Increased Coverage, Cost Savings, and Preference for Routine Polio Immunization with Tropis® ID Needle-free Delivery

October 24, 2024 UCBN News, Syndication Comments Off on PharmaJet Announces Implementation Study Results: Increased Coverage, Cost Savings, and Preference for Routine Polio Immunization with Tropis® ID Needle-free Delivery

GOLDEN, Colo.–(BUSINESS WIRE)–Routine polio immunization implementation study in Nigeria shows increased coverage, cost savings and preference for PharmaJet Tropis ID delivery.
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks

Related Articles

No Picture
News

Ginkgo Bioworks handed a DARPA manufacturing contract; Merck hits a primary endpoint for Keytruda in first-line cervical cancer

July 19, 2023 UCBN News, Syndication Comments Off on Ginkgo Bioworks handed a DARPA manufacturing contract; Merck hits a primary endpoint for Keytruda in first-line cervical cancer

The Defense Advanced Research Projects Agency (DARPA) is giving Ginkgo Bioworks a 4-year contract worth up to $18 million, to manufacture complex therapeutic proteins. Ginkgo is part of DARPA’s “Reimagining Protein Manufacturing project,” which is […]